Peer Review History
| Original SubmissionApril 14, 2025 |
|---|
|
PONE-D-25-18637-->-->What does it mean to have experienced the death of a relative in a context of social and funeral restrictions? Lessons from the pandemic for bereavement research and clinical practice.-->-->PLOS ONE?> Dear Dr. Boever, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== The reviewers have completed their assessment of your manuscript, and while they found it engaging, they raised several significant concerns that need to be addressed. I concur with the reviewers, particularly regarding methodological issues. Specifically, your description of the analytic process appears more consistent with thematic analysis than with interpretative phenomenology (IP), and your Results section tends toward description rather than interpretation. Additionally, I recommend you carefully reconsider the conceptual clarity around your use of the term "paradox," as it is frequently employed to characterize participants' dilemmas or experiential tensions. Please submit your revised manuscript by Aug 15 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Michal Mahat-Shamir, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met. Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript. 3. Thank you for stating in your Funding Statement: “CB was supported by a Grant "Fonds pour la Recherche en Sciences Humaines" (FRESH) from the "Fonds de la recherche Scientifique" (F.N.R.S.-F.R.S.) [number 1.F.010.22F.] website : https://www.frs-fnrs.be/fr/financements/chercheur-doctorant#fresh They did not play any role in the study design or any step of the research.” Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 4. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 5. Thank you for stating the following in the Acknowledgments Section of your manuscript: “This research was generously supported by a FRESH (F.N.R.S.-F.R.S.) Grant to CB [number 1.F.010.22F.]” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “CB was supported by a Grant "Fonds pour la Recherche en Sciences Humaines" (FRESH) from the "Fonds de la recherche Scientifique" (F.N.R.S.-F.R.S.) [number 1.F.010.22F.] website : https://www.frs-fnrs.be/fr/financements/chercheur-doctorant#fresh They did not play any role in the study design or any step of the research.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 6. Please remove all personal information, ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Note: spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: I have two major concerns that need to be addressed before this manuscript can be considered for publication, as well as several additional suggestions for improvement. 1. Methodological Concerns – Interpretive Phenomenology The description of the analysis process aligns more closely with thematic analysis than with the principles of interpretive phenomenology (IP). One of the core tenets of IP is its idiographic commitment, which typically involves a detailed, in-depth examination of a small, homogenous sample. In the current manuscript, it is unclear how these foundational principles were implemented. Moreover, the Results section reads primarily as descriptive rather than interpretive. I encourage the authors to consult exemplar IP studies to better understand how to move beyond surface-level description toward deeper interpretive engagement with participants’ lived experiences. 2. Conceptual Clarity – Use of the Term "Paradox" The manuscript frequently employs the term paradox to describe participants’ dilemmas or experiential tensions. However, a paradox is generally understood as a situation or statement that appears self-contradictory or illogical, but which may hold a deeper truth upon closer examination. Most of the examples presented reflect internal conflicts, tensions, or identity struggles—not paradoxes in the strict sense. I recommend that the authors either define the term more clearly or consider replacing it with more appropriate concepts such as conflict, ambivalence, or tension. 3. Additional Comments The lack of alignment between the research questions and the interview guide should be explicitly acknowledged and explained in the Method section. Including sample interview questions would enhance transparency and clarify how data were elicited. The statement that the researchers aimed “not to influence participants’ answers” (p. 9, line 243) reflects a positivist stance that does not align with the ontological and epistemological assumptions of interpretive research. I encourage the authors to reconsider this framing in light of their chosen paradigm. The Discussion section could be more concise and focused. Reducing its length and sharpening its analytical insights would improve its overall impact. Addressing these issues would substantially strengthen the conceptual, methodological, and analytical coherence of the manuscript. Reviewer #2: Abstract •The abstract presents the objective, research context, and methodology, and includes three main findings. However, the findings are presented as general formulations ("experience full of paradoxes," "multitude of experiences, very different from what had been imagined," "finding their own way to make sense of their experiences") rather than in a way that characterizes the unique insights of the research. •The clinical and research implications are mentioned in overly general terms. It could be more effective to include one concrete example of a clinical implication (e.g., the importance of acknowledging paradoxes as part of grieving processes) to illustrate the practical value of the findings. Introduction •Despite grief being the central concept, there is only partial reference to this concept, with a lack of reference to grief in general and not only in the context of COVID-19. The introduction focuses primarily on the potential effects of COVID-19 restrictions on bereaved individuals, but lacks presentation of basic theoretical background on grief processes in general. There is no definition of what grief is, how it typically manifests, or what the central theories in the field are. In the absence of this "baseline," it is difficult for readers unfamiliar with the content domain to understand the full significance of the disruptions caused by COVID-19 in this area. Method •The study mentions that the analysis was conducted with the involvement of additional researchers to ensure reliability (triangulation), but lacks a detailed description of the methodological process for handling disagreements between researchers. It is unclear how discussions were conducted when there were different interpretations of the same data, or what the criteria for decision-making were. This information is vital for assessing the reliability of the findings and methodological transparency. Findings •There is a notable imbalance in length between themes: Theme 2 spans 155 lines compared to 88 lines in Theme 1, creating a disproportionate presentation. •There is repetition of key ideas - for example, the need for physical and social contact is mentioned at least three times in the same basic descriptive manner, and the sense of unreality recurs four times in identical contexts. While repetition of findings in qualitative research can strengthen their reliability and emphasize their importance, each repeated mention should add a new layer, deepen understanding, reveal a different angle, or connect to other themes. Discussion •The discussion ends mid-thought without a comprehensive summary or clear conclusions, leaving a sense of incompleteness. •There is a mismatch between the limited sample (12 participants) and the general claims in the discussion, where the authors use language such as "people experienced multiple paradoxes" as if representing the entire population, raising significant questions about generalizability and requiring more explicit acknowledgment of research limitations. Clinical and Research Implications •The clinical recommendations are too general and lack concrete guidelines - for example, how exactly to "identify paradoxes" or "explore emotions arising from meaning-making" in actual practice. •The new concept "grieving for the ideal goodbye" is mentioned as a clinical implication but lacks detail on how to identify it in treatment and what specific interventions are recommended for this condition. •The research implications are too broad ("include mediators," "person-centered approaches") and need more specific elaboration regarding which mediators and which methodologies exactly are recommended. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Dr. Yael Doft ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
What does it mean to have experienced the death of a relative in a context of social and funeral restrictions? Lessons from the pandemic for bereavement research and clinical practice. PONE-D-25-18637R1 Dear Dr. Boever, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Michal Mahat-Shamir, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): I have carefully reviewed the revisions and amendments made by the authors to the manuscript, as well as their responses to the reviewers’ comments. I am impressed by the thorough and comprehensive work that has been done, particularly in aligning the writing with the principles of IPA. I greatly appreciate the effort invested and find the manuscript, in its current version, suitable for publication. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-18637R1 PLOS ONE Dear Dr. Boever, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Michal Mahat-Shamir Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .